• Je něco špatně v tomto záznamu ?

Phagocytosis-Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention

M. Hortová-Kohoutková, F. Tidu, M. De Zuani, V. Šrámek, M. Helán, J. Frič

. 2020 ; 54 (5) : 606-614. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004829

Phagocytosis is a complex process by which cells within most organ systems remove pathogens and cell debris. Phagocytosis is usually followed by inflammatory pathway activation, which promotes pathogen elimination and inhibits pathogen growth. Delayed pathogen elimination is the first step in sepsis development and a key factor in sepsis resolution. Phagocytosis thus has an important role during sepsis and likely contributes to all of its clinical stages. However, only a few studies have specifically explored and characterized phagocytic activity during sepsis. Here, we describe the phagocytic processes that occur as part of the immune response preceding sepsis onset and identify the elements of phagocytosis that might constitute a predictive marker of sepsis outcomes. First, we detail the key features of phagocytosis, including the main receptors and signaling hallmarks associated with different phagocytic processes. We then discuss how the initial events of phagosome formation and cytoskeletal remodeling might be associated with known sepsis features, such as a cytokine-driven hyperinflammatory response and immunosuppression. Finally, we highlight the unresolved mechanisms of sepsis development and progression and the need for cross-disciplinary approaches to link the clinical complexity of the disease with basic cellular and molecular mechanisms.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004829
003      
CZ-PrNML
005      
20220228092541.0
007      
ta
008      
220113s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/SHK.0000000000001541 $2 doi
035    __
$a (PubMed)32516170
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hortová-Kohoutková, Marcela $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
245    10
$a Phagocytosis-Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention / $c M. Hortová-Kohoutková, F. Tidu, M. De Zuani, V. Šrámek, M. Helán, J. Frič
520    9_
$a Phagocytosis is a complex process by which cells within most organ systems remove pathogens and cell debris. Phagocytosis is usually followed by inflammatory pathway activation, which promotes pathogen elimination and inhibits pathogen growth. Delayed pathogen elimination is the first step in sepsis development and a key factor in sepsis resolution. Phagocytosis thus has an important role during sepsis and likely contributes to all of its clinical stages. However, only a few studies have specifically explored and characterized phagocytic activity during sepsis. Here, we describe the phagocytic processes that occur as part of the immune response preceding sepsis onset and identify the elements of phagocytosis that might constitute a predictive marker of sepsis outcomes. First, we detail the key features of phagocytosis, including the main receptors and signaling hallmarks associated with different phagocytic processes. We then discuss how the initial events of phagosome formation and cytoskeletal remodeling might be associated with known sepsis features, such as a cytokine-driven hyperinflammatory response and immunosuppression. Finally, we highlight the unresolved mechanisms of sepsis development and progression and the need for cross-disciplinary approaches to link the clinical complexity of the disease with basic cellular and molecular mechanisms.
650    _2
$a zvířata $7 D000818
650    _2
$a cytokiny $x imunologie $7 D016207
650    _2
$a lidé $7 D006801
650    17
$a imunosupresivní léčba $7 D007165 $2 czmesh
650    12
$a fagocytóza $7 D010587
650    _2
$a sepse $x imunologie $x patologie $7 D018805
650    _2
$a signální transdukce $x imunologie $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Tidu, Federico $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a De Zuani, Marco $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Šrámek, Vladimír $u Department of Anesthesiology and Intensive Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Helán, Martin $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Anesthesiology and Intensive Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Frič, Jan $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
773    0_
$w MED00158650 $t Shock (Augusta, Ga.) $x 1540-0514 $g Roč. 54, č. 5 (2020), s. 606-614
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32516170 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220228092540 $b ABA008
999    __
$a ok $b bmc $g 1752124 $s 1155978
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 54 $c 5 $d 606-614 $e - $i 1540-0514 $m Shock $n Shock $x MED00158650
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...